Product

Portfolio Intelligence Portside Congress trades Super-investors Economic calendar Earnings calendar Pricing

Company

About FAQs Contact Create account

Legal

Privacy Terms Portside rules

DBD

DIEBOLD NIXDORF, Inc

COMMON STOCK · NYSE

Price and daily changeSign in

Earnings28 Oct 2026

52-week rangeSign inDay rangeSign in

Loading evidence for DBD

Market cap

Volume

Beta

Shares float

Short interest

9.24%

P/E (fwd)

PEG (fwd)

Rev growth (fwd)

Price chart (1D to 10Y)

Licensed market data — shown to members, not published to the open web.

Create free account

Overview Statistics Statements Dividends🔒Momentum🔒Quant🔒Fair Value🔒Earnings Analysts🔒Insiders Smart Money Options🔒Insights🔒

Trading information

Beta: Sign in
Shares outstandingAs of 2026-07-21 · filed common shares: 33.94M
Shares float: Sign in
Float %: Sign in
Insider ownershipDirectors and officers, from their latest Form 3/4/5 holding: 1.25%
Institutional ownership: Sign in
Short interestShare of shares outstanding, at settlement: 9.24%
Short ratioDays to cover, as published by FINRA: 11.91
Short volume (5D)Share of FINRA reporting-facility volume sold short, daily flow: 80.20%
Short volume (20D)Share of FINRA reporting-facility volume sold short, daily flow: 74.40%
Avg volume (10D)

See the full stock page

Prices, charts, ranges, valuation ratios, dividends, momentum and analyst estimates are licensed for signed-in members. A free account opens every stock, fund and crypto page.

Create free account

Source: SEC filings. Information and analytics, not investment advice.

Avg volume (3 months)

Profitability

Gross marginTTM to Jun 26: 25.24%
Operating marginTTM to Jun 26: 6.36%
Net margin: —
EBITDA marginTTM to Jun 26: 9.58%
Return on equityNet income (TTM to Jun 26) ÷ average shareholders equity: 10.76%
Return on assetsNet income (TTM to Jun 26) ÷ average total assets: 2.97%

Growth

Revenue growth (annual YoY): 1.46%
Revenue growth (latest qtr YoY): 1.70%
Revenue growth (fwd): Sign in
Net income growth (annual YoY): —
Net income growth (latest qtr YoY): 27.05%
EPS growth (fwd): Sign in
Net income growth (QoQ): 210.00%

Valuation

Market cap: Sign in
Enterprise value: Sign in
P/E: Sign in
P/E (fwd): Sign in
PEG: Sign in
PEG (fwd): Sign in
Price / book: Sign in
Price / sales

Price / operating cash flow

P/FCF

EV / revenue

EV / EBITDA

EPSDiluted, TTM to Jun 26

3.02

EPS (fwd)

Financial health

Cash & equivalentsas of Jun 26: $282.40M
Total cash: Sign in
Total debtBorrowings + finance and operating lease liabilities, as of Jun 26: $1.10B
Debt / equityas of Jun 26: 114.40%
Current ratioas of Jun 26: 1.27
Quick ratio(Cash + marketable securities + receivables) ÷ current liabilities, as of Jun 26: 0.63
Operating cash flowTTM to Jun 26: $273.00M
Free cash flow (nine months)Nine months: 2025-01-01 to 2025-09-30 · Not annualized: $64.80M
TTM revenue / diluted shareDiluted, TTM to Jun 26: 107.03

DBD stock Statistics — DIEBOLD NIXDORF, Inc filings, insiders & smart money · Instaport